HA- Gepants DI Flashcards
Gepant used in migraine treatment
Rimegepant, ubrogepant, atogepant
Rimegepant brand name
Nurtec
Ubrogepant brand name
Ubrevly
Atogepant brand name
Qulipta
Gepant MoA
Small molecule CGRP receptor antagonists
Rimegepant indications
Acute AND preventative treatment of migraine in adults
Rimegepant dosing
Acute: 75mg PO x1
Preventative: 75mg PO QOD
Rimegepant side effects
Abdominal pain, dyspepsia, nausea
Usually well tolerated though
Rimegepant CIs
CrCl ≤15ml/min, severe hepatic impairment
Ubrogepant indications
Acute treatment of migraine with or without aura
Ubrogepant dosing
50-100mg PO x1, can repeat dose after ≥2 hours
When Ubrevly needs a dose adjustment
CrCl <30ml/min, avoid use in <15 ml/min
Ubrogepant ADEs
Nausea, drowsiness, xerostomia
Ubrogepant CI
Strong 3A4 inhibitors
Ubrogepant Tmax
1.5 hours, but administration with a high-fat meal delays it by 2 hours
Atogepant indications
PREVENTATIVE treatment of episodic migraine
Atogepant dosing
10, 30, or 60mg x1
Atogepant dose adjustment
<30 ml/min
Atogepant ADEs
Constipation, nausea, drowsiness, fatigue, weight loss
Atogepant is not recommended in what?
Severe hepatic impairment
Adequate trial length of atogepant
8 weeks